Technology
Health
Biotechnology

Ultragenyx Pharmaceutical

254

$36.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.50 (-1.34%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours

Why Robinhood?

You can buy or sell RARE and other stocks, options, ETFs, and crypto commission-free!

About RARE

Ultragenyx Pharmaceutical Inc. Common Stock, also called Ultragenyx Pharmaceutical, is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Read More Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

CEO
Emil D. Kakkis
Employees
610
Headquarters
Novato, California
Founded
2010
Market Cap
2.12B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
518.32K
High Today
$37.21
Low Today
$36.30
Open Price
$36.80
Volume
532.01K
52 Week High
$74.50
52 Week Low
$36.13

Collections

Technology
Health
Biotechnology
Pharmaceutical
Biopharmaceutical
2014 IPO
US
North America

RARE News

ReutersNov 9

Edited Transcript of RARE earnings conference call or presentation 5-Nov-19 10:00pm GMT

Q3 2019 Ultragenyx Pharmaceutical Inc Earnings Call Novato Nov 9, 2019 (Thomson StreetEvents) -- Edited Transcript of Ultragenyx Pharmaceutical Inc earnings co
1

RARE Earnings

-$2.09
-$1.46
-$0.84
-$0.21
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$1.68 per share
Actual
-$1.96 per share
Replay Earnings Call

You May Also Like

KXIN
JMHLY
SMNNY
ALV
UBG
GEO
HHHH
FAN
HIBS
PCI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy RARE

Market Price$36.78
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell RARE stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up